How do you decide if a patient is right for a clinical trial at Hopkins?

“Every clinical trial is done in a way to try to get a very homogenous group of patients, so we can better draw conclusions about whether the innovation we’re testing is actually working,” says radiation oncologist Russell K. Hales, M.D. of the Johns Hopkins Kimmel Cancer Center on the Johns Hopkins Bayview campus.

“A patient can be evaluated for a clinical trial, and we would look carefully at the stage of their disease, at their overall health, and at other factors to determine whether they're appropriate candidates for a clinical trial,” Hales added. “Clinical trials are available for patients with all stages of disease, from early stage disease to very advanced disease, and for patients newly diagnosed, as well as for those with recurrent disease. Trials are not one-size-fits-all. They're custom made for patients at varying points on the continuum of lung cancer treatment.”

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
No Comments

Leave a Comment

You can use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Johns Hopkins Medicine does not necessarily endorse, nor does Johns Hopkins Medicine edit or control, the content of posted comments by third parties on this website. However, Johns Hopkins Medicine reserves the right to remove any such postings that come to the attention of Johns Hopkins Medicine which are deemed to contain objectionable or inappropriate content. Read our Commenting Disclaimer.

Previous post:

Next post: